299 related articles for article (PubMed ID: 16292998)
1. Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence.
Nofer JR; Walter M; Assmann G
Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1071-86. PubMed ID: 16292998
[TBL] [Abstract][Full Text] [Related]
2. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
Kontush A; Chapman MJ
Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoproteins, inflammation and oxidative stress.
Tabet F; Rye KA
Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
Malle E; Marsche G; Panzenboeck U; Sattler W
Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis.
Nofer JR; Brodde MF; Kehrel BE
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):726-35. PubMed ID: 20337657
[TBL] [Abstract][Full Text] [Related]
6. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
Vaziri ND
J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoproteins: an emerging target in the prevention of cardiovascular disease.
Cutri BA; Hime NJ; Nicholls SJ
Cell Res; 2006 Oct; 16(10):799-808. PubMed ID: 17016470
[TBL] [Abstract][Full Text] [Related]
8. Antiinflammatory properties of HDL.
Barter PJ; Nicholls S; Rye KA; Anantharamaiah GM; Navab M; Fogelman AM
Circ Res; 2004 Oct; 95(8):764-72. PubMed ID: 15486323
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
Chapman MJ
Pharmacol Ther; 2006 Sep; 111(3):893-908. PubMed ID: 16574234
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.
Barter PJ; Rye KA
Curr Opin Lipidol; 2006 Aug; 17(4):399-403. PubMed ID: 16832163
[TBL] [Abstract][Full Text] [Related]
11. [Advances in apolipoprotein A- I and it's anti-atherosclerosis properties].
Li M; Liu ZM
Sheng Wu Gong Cheng Xue Bao; 2003 Jul; 19(4):387-91. PubMed ID: 15969051
[TBL] [Abstract][Full Text] [Related]
12. Multiple actions of high-density lipoprotein.
Florentin M; Liberopoulos EN; Wierzbicki AS; Mikhailidis DP
Curr Opin Cardiol; 2008 Jul; 23(4):370-8. PubMed ID: 18520722
[TBL] [Abstract][Full Text] [Related]
13. Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids.
Nofer JR; Assmann G
Trends Cardiovasc Med; 2005 Oct; 15(7):265-71. PubMed ID: 16226682
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein function recent advances.
Ansell BJ; Watson KE; Fogelman AM; Navab M; Fonarow GC
J Am Coll Cardiol; 2005 Nov; 46(10):1792-8. PubMed ID: 16286161
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
Sherman CB; Peterson SJ; Frishman WH
Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
[TBL] [Abstract][Full Text] [Related]
16. HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL.
Pu DR; Liu L
Med Hypotheses; 2008; 70(2):338-42. PubMed ID: 17640824
[TBL] [Abstract][Full Text] [Related]
17. [Antiatherogenic effect of high density lipoprotein].
Turczyn B; Skoczyńska A
Postepy Hig Med Dosw; 2002; 56(4):499-520. PubMed ID: 12418415
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoprotein (HDL) from elderly and reconstituted HDL containing glycated apolipoproteins A-I share proatherosclerotic and prosenescent properties with increased cholesterol influx.
Park KH; Cho KH
J Gerontol A Biol Sci Med Sci; 2011 May; 66(5):511-20. PubMed ID: 21415260
[TBL] [Abstract][Full Text] [Related]
19. Genetics of high-density lipoproteins.
Dastani Z; Engert JC; Genest J; Marcil M
Curr Opin Cardiol; 2006 Jul; 21(4):329-35. PubMed ID: 16755202
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.
Wolfrum C; Poy MN; Stoffel M
Nat Med; 2005 Apr; 11(4):418-22. PubMed ID: 15793583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
